1H3 — Clearbridge Health Balance Sheet
0.000.00%
- SG$6.51m
- SG$10.29m
- SG$9.90m
- 15
- 47
- 19
- 13
Annual balance sheet for Clearbridge Health, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14 | 14.6 | 6.05 | 4.48 | 4.29 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 9.26 | 8.25 | 3.43 | 2.84 | 3.18 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 30.8 | 31.1 | 10.8 | 8.51 | 7.99 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8.89 | 6.47 | 2.1 | 3.27 | 2.07 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 97 | 82.7 | 58.2 | 23.9 | 21.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 19.6 | 17.2 | 5.1 | 4.91 | 9.19 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 36.5 | 30.5 | 16.8 | 13.7 | 12 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 60.5 | 52.2 | 41.4 | 10.2 | 9.21 |
Total Liabilities & Shareholders' Equity | 97 | 82.7 | 58.2 | 23.9 | 21.2 |
Total Common Shares Outstanding |